Drug
Cefotaxime
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Reaction With Eosinophilia And Systemic Symptoms | 240 | 46.5 | 49.2 | signal |
| 2 | Toxic Epidermal Necrolysis | 129 | 42.3 | 43.6 | signal |
| 3 | Hepatocellular Injury | 113 | 39.3 | 40.3 | signal |
| 4 | Clostridium Difficile Colitis | 65 | 30.2 | 30.6 | signal |
| 5 | Eosinophilia | 95 | 26.8 | 27.4 | signal |
| 6 | Rash Maculo-papular | 116 | 25.8 | 26.5 | signal |
| 7 | Hepatic Cytolysis | 51 | 20.5 | 20.8 | signal |
| 8 | Agranulocytosis | 73 | 19.4 | 19.8 | signal |
| 9 | Toxic Skin Eruption | 35 | 17.0 | 17.2 | signal |
| 10 | Cholestasis | 60 | 15.4 | 15.7 | signal |
| 11 | Hyperbilirubinaemia | 32 | 15.3 | 15.4 | signal |
| 12 | Hypotonia | 30 | 14.7 | 14.8 | signal |
| 13 | Disseminated Intravascular Coagulation | 42 | 14.6 | 14.8 | signal |
| 14 | Multiple Organ Dysfunction Syndrome | 78 | 13.7 | 14.0 | signal |
| 15 | Septic Shock | 105 | 11.9 | 12.2 | signal |
| 16 | Brain Oedema | 30 | 11.7 | 11.7 | signal |
| 17 | Thrombotic Microangiopathy | 23 | 11.7 | 11.7 | signal |
| 18 | Drug Resistance | 55 | 10.5 | 10.6 | signal |
| 19 | Encephalopathy | 52 | 10.4 | 10.5 | signal |
| 20 | Status Epilepticus | 24 | 10.4 | 10.5 | signal |
| 21 | Premature Baby | 64 | 10.4 | 10.6 | signal |
| 22 | Transaminases Increased | 43 | 9.5 | 9.6 | signal |
| 23 | Stevens-johnson Syndrome | 43 | 9.5 | 9.6 | signal |
| 24 | Leukocytosis | 33 | 9.0 | 9.0 | signal |
| 25 | Coagulopathy | 28 | 8.3 | 8.3 | signal |
| 26 | Posterior Reversible Encephalopathy Syndrome | 16 | 8.3 | 8.3 | signal |
| 27 | Electrolyte Imbalance | 19 | 8.1 | 8.1 | signal |
| 28 | Generalised Tonic-clonic Seizure | 27 | 8.1 | 8.1 | signal |
| 29 | Acute Respiratory Distress Syndrome | 29 | 8.0 | 8.1 | signal |
| 30 | Candida Infection | 27 | 7.9 | 8.0 | signal |
| 31 | Respiratory Distress | 44 | 7.8 | 7.9 | signal |
| 32 | Erythema Multiforme | 14 | 7.4 | 7.4 | signal |
| 33 | Tachypnoea | 20 | 7.2 | 7.3 | signal |
| 34 | Pancytopenia | 77 | 6.8 | 6.9 | signal |
| 35 | Generalised Oedema | 17 | 6.8 | 6.8 | signal |
| 36 | Gamma-glutamyltransferase Increased | 30 | 6.6 | 6.7 | signal |
| 37 | Lymphopenia | 19 | 6.6 | 6.7 | signal |
| 38 | Thrombocytopenia | 150 | 6.6 | 6.8 | signal |
| 39 | Electrocardiogram Qt Prolonged | 48 | 6.5 | 6.6 | signal |
| 40 | Face Oedema | 22 | 6.4 | 6.4 | signal |
| 41 | Acute Kidney Injury | 195 | 6.3 | 6.5 | signal |
| 42 | Neutrophil Count Increased | 13 | 6.2 | 6.2 | signal |
| 43 | Metabolic Acidosis | 40 | 6.2 | 6.3 | signal |
| 44 | Cytomegalovirus Infection | 21 | 6.2 | 6.2 | signal |
| 45 | Covid-19 Pneumonia | 15 | 6.2 | 6.2 | signal |
| 46 | Petechiae | 13 | 6.1 | 6.1 | signal |
| 47 | Altered State Of Consciousness | 26 | 5.9 | 6.0 | signal |
| 48 | Cyanosis | 19 | 5.9 | 5.9 | signal |
| 49 | Pneumocystis Jirovecii Pneumonia | 12 | 5.9 | 5.9 | signal |
| 50 | Pulmonary Hypertension | 25 | 5.9 | 5.9 | signal |
| 51 | Leukopenia | 59 | 5.8 | 5.9 | signal |
| 52 | Bone Marrow Failure | 24 | 5.8 | 5.8 | signal |
| 53 | Hepatitis | 30 | 5.8 | 5.8 | signal |
| 54 | Sepsis | 129 | 5.7 | 5.8 | signal |
| 55 | Oral Candidiasis | 15 | 5.7 | 5.7 | signal |
| 56 | Anaphylactic Shock | 29 | 5.6 | 5.6 | signal |
| 57 | Hepatomegaly | 11 | 5.5 | 5.5 | signal |
| 58 | Neutropenia | 149 | 5.4 | 5.6 | signal |
| 59 | Multi-organ Failure | 19 | 5.3 | 5.3 | signal |
| 60 | Drug Eruption | 19 | 5.3 | 5.3 | signal |
| 61 | Abscess | 17 | 5.2 | 5.2 | signal |
| 62 | Circulatory Collapse | 18 | 5.2 | 5.2 | signal |
| 63 | Shock | 24 | 5.2 | 5.2 | signal |
| 64 | Cardiogenic Shock | 15 | 5.2 | 5.2 | signal |
| 65 | Bronchospasm | 15 | 5.1 | 5.2 | signal |
| 66 | Hypokalaemia | 48 | 5.1 | 5.2 | signal |
| 67 | C-reactive Protein Increased | 38 | 5.1 | 5.2 | signal |
| 68 | Hyperkalaemia | 36 | 5.1 | 5.1 | signal |
| 69 | Sudden Death | 11 | 5.0 | 5.1 | signal |
| 70 | Lactic Acidosis | 33 | 5.0 | 5.1 | signal |
| 71 | Renal Tubular Necrosis | 10 | 5.0 | 5.0 | signal |
| 72 | Myoclonus | 12 | 4.9 | 4.9 | signal |
| 73 | Nephropathy Toxic | 11 | 4.8 | 4.9 | signal |
| 74 | Pancreatitis Acute | 22 | 4.8 | 4.9 | signal |
| 75 | Pulmonary Congestion | 13 | 4.8 | 4.8 | signal |
| 76 | Hypoxia | 34 | 4.8 | 4.8 | signal |
| 77 | Pneumothorax | 15 | 4.6 | 4.7 | signal |
| 78 | Respiratory Failure | 69 | 4.6 | 4.7 | signal |
| 79 | Acute Respiratory Failure | 18 | 4.6 | 4.6 | signal |
| 80 | Foetal Exposure During Pregnancy | 76 | 4.6 | 4.7 | signal |
| 81 | Blood Creatinine Increased | 61 | 4.6 | 4.6 | signal |
| 82 | Body Temperature Increased | 19 | 4.6 | 4.6 | signal |
| 83 | Hepatic Failure | 28 | 4.5 | 4.6 | signal |
| 84 | Ataxia | 11 | 4.5 | 4.5 | signal |
| 85 | Neurotoxicity | 16 | 4.5 | 4.5 | signal |
| 86 | Muscle Rigidity | 11 | 4.5 | 4.5 | signal |
| 87 | Rhabdomyolysis | 38 | 4.5 | 4.5 | signal |
| 88 | Blood Alkaline Phosphatase Increased | 22 | 4.3 | 4.4 | signal |
| 89 | Peritonitis | 18 | 4.3 | 4.3 | signal |
| 90 | Hepatic Encephalopathy | 8 | 4.2 | 4.2 | signal |
| 91 | Tubulointerstitial Nephritis | 16 | 4.2 | 4.2 | signal |
| 92 | Diarrhoea Haemorrhagic | 8 | 4.2 | 4.2 | signal |
| 93 | Bacteraemia | 10 | 4.2 | 4.2 | signal |
| 94 | Proteinuria | 16 | 4.2 | 4.2 | signal |
| 95 | Platelet Count Increased | 11 | 4.1 | 4.1 | signal |
| 96 | Neuroleptic Malignant Syndrome | 10 | 4.1 | 4.1 | signal |
| 97 | Liver Disorder | 37 | 4.1 | 4.1 | signal |
| 98 | Respiratory Depression | 10 | 4.0 | 4.0 | signal |
| 99 | Pyrexia | 280 | 4.0 | 4.2 | signal |
| 100 | Lymphadenopathy | 28 | 3.9 | 3.9 | signal |
| 101 | Clostridium Difficile Infection | 17 | 3.8 | 3.9 | signal |
| 102 | Ventricular Tachycardia | 13 | 3.8 | 3.9 | signal |
| 103 | Skin Reaction | 11 | 3.8 | 3.8 | signal |
| 104 | Blood Urea Increased | 13 | 3.8 | 3.8 | signal |
| 105 | Oxygen Saturation Decreased | 43 | 3.8 | 3.8 | signal |
| 106 | Pallor | 21 | 3.8 | 3.8 | signal |
| 107 | International Normalised Ratio Increased | 22 | 3.7 | 3.8 | signal |
| 108 | Hemiparesis | 13 | 3.7 | 3.7 | signal |
| 109 | Urosepsis | 7 | 3.7 | 3.7 | signal |
| 110 | Bradycardia | 40 | 3.7 | 3.7 | signal |
| 111 | Premature Delivery | 12 | 3.7 | 3.7 | signal |
| 112 | Renal Failure Acute | 32 | 3.6 | 3.7 | signal |
| 113 | Aspiration | 8 | 3.6 | 3.6 | signal |
| 114 | Rash Erythematous | 34 | 3.6 | 3.6 | signal |
| 115 | Red Blood Cell Sedimentation Rate Increased | 8 | 3.5 | 3.5 | signal |
| 116 | Bacterial Infection | 13 | 3.4 | 3.4 | signal |
| 117 | Brain Injury | 7 | 3.4 | 3.4 | signal |
| 118 | Blood Lactate Dehydrogenase Increased | 11 | 3.4 | 3.4 | signal |
| 119 | Cardio-respiratory Arrest | 29 | 3.4 | 3.4 | signal |
| 120 | Rash Generalised | 18 | 3.4 | 3.4 | signal |
| 121 | Blood Creatine Phosphokinase Increased | 20 | 3.4 | 3.4 | signal |
| 122 | Pneumonia Aspiration | 17 | 3.3 | 3.4 | signal |
| 123 | Renal Failure | 91 | 3.3 | 3.4 | signal |
| 124 | Cerebral Haemorrhage | 24 | 3.3 | 3.3 | signal |
| 125 | Rash Papular | 15 | 3.3 | 3.3 | signal |
| 126 | Tachycardia | 59 | 3.3 | 3.3 | signal |
| 127 | Drug Interaction | 105 | 3.2 | 3.3 | signal |
| 128 | Drug-induced Liver Injury | 20 | 3.2 | 3.2 | signal |
| 129 | Cardiac Arrest | 53 | 3.1 | 3.2 | signal |
| 130 | Coma | 30 | 3.1 | 3.1 | signal |
| 131 | Anaemia | 120 | 3.1 | 3.1 | signal |
| 132 | Aphasia | 19 | 3.1 | 3.1 | signal |
| 133 | Subdural Haematoma | 9 | 3.1 | 3.1 | signal |
| 134 | Intestinal Perforation | 7 | 3.1 | 3.1 | signal |
| 135 | Aspartate Aminotransferase Increased | 33 | 3.0 | 3.1 | signal |
| 136 | Gastroenteritis | 9 | 3.0 | 3.0 | signal |
| 137 | Myocardial Ischaemia | 7 | 3.0 | 3.0 | signal |
| 138 | Drug Level Increased | 10 | 3.0 | 3.0 | signal |
| 139 | Hepatic Function Abnormal | 22 | 2.9 | 2.9 | signal |
| 140 | Pneumonitis | 16 | 2.9 | 2.9 | signal |
| 141 | Hypothermia | 6 | 2.9 | 2.9 | signal |
| 142 | Device Related Infection | 9 | 2.9 | 2.9 | signal |
| 143 | Exposure During Pregnancy | 36 | 2.8 | 2.9 | signal |
| 144 | Hypoglycaemia | 28 | 2.8 | 2.8 | signal |
| 145 | Ventricular Extrasystoles | 6 | 2.8 | 2.8 | signal |
| 146 | Mucosal Inflammation | 15 | 2.8 | 2.8 | signal |
| 147 | Renal Impairment | 48 | 2.8 | 2.8 | signal |
| 148 | White Blood Cell Count Increased | 22 | 2.8 | 2.8 | signal |
| 149 | Colitis | 21 | 2.7 | 2.7 | signal |
| 150 | Lethargy | 32 | 2.7 | 2.7 | signal |
| 151 | Drug Ineffective For Unapproved Indication | 30 | 2.6 | 2.7 | signal |
| 152 | Liver Injury | 13 | 2.6 | 2.6 | signal |
| 153 | Alanine Aminotransferase Increased | 33 | 2.6 | 2.6 | signal |
| 154 | Haemoptysis | 15 | 2.6 | 2.6 | signal |
| 155 | Pulmonary Oedema | 24 | 2.6 | 2.6 | signal |
| 156 | Grand Mal Convulsion | 5 | 2.6 | 2.6 | no signal |
| 157 | Respiratory Disorder | 16 | 2.6 | 2.6 | signal |
| 158 | Pulmonary Fibrosis | 10 | 2.6 | 2.6 | signal |
| 159 | Sinus Bradycardia | 5 | 2.5 | 2.5 | no signal |
| 160 | Acute Hepatic Failure | 7 | 2.5 | 2.5 | signal |
| 161 | Vasculitis | 6 | 2.5 | 2.5 | signal |
| 162 | Dystonia | 10 | 2.5 | 2.5 | signal |
| 163 | Blood Iron Decreased | 6 | 2.5 | 2.5 | no signal |
| 164 | Febrile Neutropenia | 33 | 2.4 | 2.5 | signal |
| 165 | Rash Macular | 17 | 2.4 | 2.4 | signal |
| 166 | Hypercalcaemia | 6 | 2.4 | 2.4 | no signal |
| 167 | Liver Function Test Abnormal | 14 | 2.3 | 2.4 | signal |
| 168 | Hallucination, Visual | 10 | 2.3 | 2.3 | signal |
| 169 | Interstitial Lung Disease | 23 | 2.3 | 2.3 | signal |
| 170 | Jaundice | 12 | 2.2 | 2.2 | signal |
| 171 | Osteomyelitis | 8 | 2.2 | 2.2 | no signal |
| 172 | Gingival Bleeding | 6 | 2.2 | 2.2 | no signal |
| 173 | Cardiac Failure | 34 | 2.1 | 2.1 | signal |
| 174 | Product Prescribing Error | 10 | 2.1 | 2.1 | signal |
| 175 | Nervous System Disorder | 13 | 2.0 | 2.0 | signal |
| 176 | Fluid Overload | 6 | 2.0 | 2.0 | no signal |
| 177 | Drug Withdrawal Syndrome Neonatal | 6 | 2.0 | 2.0 | no signal |
| 178 | Product Administration Error | 8 | 2.0 | 2.0 | no signal |
| 179 | Contraindicated Product Administered | 12 | 2.0 | 2.0 | no signal |
| 180 | Maternal Exposure During Pregnancy | 35 | 1.9 | 2.0 | no signal |
| 181 | Drug Level Decreased | 4 | 1.9 | 1.9 | no signal |
| 182 | Mydriasis | 5 | 1.9 | 1.9 | no signal |
| 183 | Transfusion | 4 | 1.9 | 1.9 | no signal |
| 184 | Gastrointestinal Haemorrhage | 31 | 1.8 | 1.8 | no signal |
| 185 | Serotonin Syndrome | 7 | 1.8 | 1.8 | no signal |
| 186 | Dialysis | 5 | 1.7 | 1.7 | no signal |
| 187 | Pulmonary Arterial Hypertension | 5 | 1.7 | 1.7 | no signal |
| 188 | Caesarean Section | 4 | 1.7 | 1.7 | no signal |
| 189 | Ischaemic Stroke | 6 | 1.6 | 1.6 | no signal |
| 190 | Haemorrhage Intracranial | 5 | 1.6 | 1.6 | no signal |
| 191 | Accidental Overdose | 12 | 1.6 | 1.6 | no signal |
| 192 | Angioedema | 14 | 1.6 | 1.6 | no signal |
| 193 | Convulsion | 18 | 1.5 | 1.5 | no signal |
| 194 | Drug Toxicity | 4 | 1.4 | 1.4 | no signal |
| 195 | Metrorrhagia | 5 | 1.4 | 1.4 | no signal |
| 196 | Cytokine Release Syndrome | 5 | 1.3 | 1.3 | no signal |
| 197 | Toxicity To Various Agents | 43 | 1.3 | 1.3 | no signal |
| 198 | Myelosuppression | 8 | 1.2 | 1.2 | no signal |
| 199 | Tuberculosis | 3 | 1.1 | 1.1 | no signal |
| 200 | Injection Site Haematoma | 3 | 1.0 | 1.0 | no signal |
| 201 | Drug Exposure During Pregnancy | 6 | 0.9 | 0.9 | no signal |
| 202 | Palmar-plantar Erythrodysaesthesia Syndrome | 4 | 0.8 | 0.8 | no signal |
| 203 | Drug Effective For Unapproved Indication | 4 | 0.7 | 0.7 | no signal |
| 204 | Extrapyramidal Disorder | 3 | 0.6 | 0.6 | no signal |
| 205 | Incorrect Route Of Drug Administration | 4 | 0.5 | 0.5 | no signal |